Involvement of glutathione peroxidase activity in the stimulation of 5-lipoxygenase activity by glutathione-depleting agents in human polymorphonuclear leukocytes.

We recently demonstrated activation of 5-lipoxygenase activity in human polymorphonuclear leukocytes (PMN) on preincubation of the cells with glutathione-depleting agents, namely 1-chloro-2,4-dinitrobenzene (Dnp-C1) and azodicarboxylic acid bis[dimethylamide] (diamide). In this paper we show that Dnp-C1, but not diamide, impairs the reduction of added organic peroxides in whole PMN. Also, since co-incubation of fatty acid hydroperoxides with arachidonate caused activation of 5-lipoxygenase, we propose that Dnp-C1 increases the peroxide level in PMN which is required for the onset of lipoxygenase activity. This could be substantiated in PMN homogenates by a glutathione-dependent depression of arachidonate 5-lipoxygenation. At higher arachidonate concentrations and in the presence of Ca2+ the glutathione effect was not observed but additional glutathione peroxidase also blocked this maximally stimulated 5-lipoxygenase. Together with other experiments, it became obvious that the formation of leukotrienes, but also of 15-lipoxygenase products, requires a sharply defined threshold level of fatty acid hydroperoxides which are generated by the lipoxygenases and counteracted by glutathione-dependent peroxidase(s). Dnp-C1 influences this equilibrium by removing glutathione and thereby inhibiting glutathione-dependent peroxidase activity. From our data we conclude that it is the physiological function of the peroxidase activity in PMN to determine an efficiently regulated threshold level of hydroperoxide products, below which no activation of 5-lipoxygenase or 15-lipoxygenase can occur.

[1]  A. Hatzelmann,et al.  The ω-hydroxylation of arachidonic acid by human polymorphonuclear leukocytes , 1988 .

[2]  C. Craik,et al.  Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties. , 1988, Biochemical and biophysical research communications.

[3]  H. Ruf,et al.  Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction. , 1988, European journal of biochemistry.

[4]  A. Hatzelmann,et al.  Regulation of 5-lipoxygenase activity by the glutathione status in human polymorphonuclear leukocytes. , 1987, European journal of biochemistry.

[5]  J. Gallin,et al.  Current concepts: immunology. Neutrophils in human diseases. , 1987, The New England journal of medicine.

[6]  C. Shelly,et al.  Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide. , 1987, Journal of Biological Chemistry.

[7]  J. Oates,et al.  Arachidonate 12-lipoxygenase purified from porcine leukocytes by immunoaffinity chromatography and its reactivity with hydroperoxyeicosatetraenoic acids. , 1986, The Journal of biological chemistry.

[8]  R. Bryant,et al.  Modulation of the 5-lipoxygenase activity of MC-9 mast cells: activation by hydroperoxides. , 1986, Prostaglandins.

[9]  R. Stein,et al.  Kinetic mechanism of guinea pig neutrophil 5-lipoxygenase. , 1986, The Journal of biological chemistry.

[10]  B. Dewald,et al.  Platelet-activating factor as a stimulus of exocytosis in human neutrophils. , 1986, Biochimica et biophysica acta.

[11]  C. Rouzer,et al.  The importance of hydroperoxide activation for the detection and assay of mammalian 5‐lipoxygenase , 1986, FEBS letters.

[12]  S. Yamamoto,et al.  Purification of arachidonate 5-lipoxygenase from porcine leukocytes and its reactivity with hydroperoxyeicosatetraenoic acids. , 1986, The Journal of biological chemistry.

[13]  C. Rouzer,et al.  Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Sumimoto,et al.  NAD+-dependent conversion of 20-OH-LTB4 to 20-COOH-LTB4 by a cell-free system of human polymorphonuclear leukocytes. , 1985, Biochemical and biophysical research communications.

[15]  B. Samuelsson,et al.  Leukotriene A4 hydrolase in human leukocytes. Purification and properties. , 1984, The Journal of biological chemistry.

[16]  R. Clancy,et al.  Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Franchi,et al.  Metabolic factors regulating the generation of prostaglandins E1 and E2 by isolated rat uterus. , 1983, Prostaglandins, leukotrienes, and medicine.

[18]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[19]  J. Palmblad,et al.  Leukotriene‐induced neutrophil aggregation in vitro , 1982, FEBS letters.

[20]  J. Maclouf,et al.  Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Oates,et al.  Arachidonic acid 15-lipoxygenase products from human eosinophils. , 1982, The Journal of biological chemistry.

[22]  B. Samuelsson,et al.  Stimulation of human leukocyte degranulation by leukotriene B4 and its ω‐oxidized metabolites , 1981 .

[23]  L. Dechatelet,et al.  Release and metabolism of arachidonic acid in human neutrophils. , 1981, The Journal of biological chemistry.

[24]  S. Dahlén,et al.  Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytes , 1981 .

[25]  B. Jakschik,et al.  Enzymatic assembly of slow reacting substance , 1980, Nature.

[26]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[27]  W. Stenson,et al.  Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. , 1979, The Journal of clinical investigation.

[28]  N. Porter,et al.  Preparation and purification of arachidonic acid hydroperoxides of biological importance , 1979 .

[29]  B. Samuelsson,et al.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Hamberg,et al.  Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Lands,et al.  Further studies of the kinetics of oxygenation of arachidonic acid by soybean lipoxygenase. , 1975, Canadian journal of biochemistry.

[32]  W. Lands,et al.  Oxygenation of unsaturated fatty acids by soybean lipoxygenase. , 1972, The Journal of biological chemistry.

[33]  B. Axelrod,et al.  Induction period in the lipoxidase-catalyzed oxidation of linoleic acid and its abolition by substrate peroxide. , 1958, The Journal of biological chemistry.

[34]  L. Flohé,et al.  Kinetic studies on arachidonate 5-lipoxygenase from rat basophilic leukemia cells. , 1988, Biological chemistry Hoppe-Seyler.

[35]  G. Weissmann,et al.  The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites. , 1987, The Biochemical journal.

[36]  R. Egan,et al.  Specific inhibition and oxidative regulation of 5-lipoxygenase. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.